Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biohaven
Biohaven
Biohaven migraine drug partnered with Pfizer lands twin European approvals
MedCity News
Wed, 04/27/22 - 10:38 pm
Europe
Pfizer
Biohaven
migraines
rimegepant
Takeover-driven resurgence fails to materialize for biotech
EP Vantage
Thu, 04/14/22 - 10:41 am
M&A
AbbVie
Biocon
Biogen
Biohaven
GSK
Halozyme Therapeutics
Samsung Bioepis
UCB
Viatris
Biohaven’s high-risk bet
EP Vantage
Mon, 03/21/22 - 10:28 pm
Biohaven
troriluzole
clinical trials
spinocerebellar ataxia
AbbVie touts Qulipta chronic migraine win as Biohaven duel heats up
Fierce Pharma
Thu, 03/10/22 - 10:22 pm
AbbVie
Biohaven
migraines
Qulipta
Nurtec
Biohaven stocks up on experimental drugs with new acquisition, licensing deal
BioPharma Dive
Sun, 02/27/22 - 10:21 pm
Biohaven
Bristol Myers Squibb
Channel Biosciences
M&A
What to Expect From Biogen's $2.3 Billion Shopping Spree
Motley Fool
Sat, 02/12/22 - 11:47 pm
Biogen
M&A
Aurinia Pharmaceuticals
Biohaven
AbbVie’s Qulipta gains ground with docs for migraine prevention, as pharma looks to pressure Biohaven’s Nurtec
Fierce Pharma
Thu, 02/10/22 - 08:02 pm
AbbVie
Biohaven
migraines
Qulipta
Nurtec ODT
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
M&A
biotech
Amylyx Pharmaceuticals
Arena Pharmaceuticals
AstraZeneca
Aurinia Pharmaceuticals
Biogen
Biohaven
Bristol Myers Squibb
Eli Lilly
GSK
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Biopharma’s stock market winners of 2021 revealed
EP Vantage
Wed, 01/12/22 - 10:50 am
biotech stocks
Eli Lilly
Pfizer
Abbott Labs
Moderna Therapeutics
Merck KGaA
Novo Nordisk
BioNTech
Biohaven
Prothena
Bicycle Therapeutics
Bellus Health
Evolus
Pfizer and Biohaven close collaboration agreements
Pharmaceutical Business Review
Thu, 01/6/22 - 10:54 am
Pfizer
Biohaven
rimegepant
zavegepant
Nurtec ODT
migraines
Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role
Fierce Biotech
Mon, 12/6/21 - 10:50 am
Biohaven
zavegepant
migraines
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working?
Fierce Pharma
Mon, 11/22/21 - 10:21 am
migraines
pharma marketing
JNJ
Topamax
Amgen
Biohaven
Eli Lilly
Teva Pharmaceutical
Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtec
Fierce Pharma
Thu, 11/18/21 - 11:03 pm
Eli Lilly
Biohaven
migraines
clinical trials
Nurtec ODT
Emgality
Biohaven, Pfizer enter up to $1.24 bln deal to market migraine drugs
Yahoo/Reuters
Tue, 11/9/21 - 10:38 am
Pfizer
Biohaven
migraines
rimegepant
zavegepant
Buckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors’ survey shows
Fierce Pharma
Fri, 10/22/21 - 12:42 pm
Biohaven
migraines
Nurtec ODT
Amgen
AbbVie
Biohaven migraine drug sales again top Wall Street forecasts
BioPharma Dive
Wed, 10/6/21 - 11:20 pm
Biohaven
migraines
Nurtec ODT
AbbVie closes in on Biohaven with new migraine prevention OK for oral CGRP drug
Endpoints
Wed, 09/29/21 - 11:04 am
AbbVie
Qulipta
migraines
Allergan
Biohaven
FDA
Biohaven's Verdiperstat Falls Flat in Multiple System Atrophy
BioSpace
Mon, 09/27/21 - 10:46 am
Biohaven
clinical trials
verdiperstat
MSA
multiple system atrophy
No joy for Ajovy: Teva's migraine drug can't find a win in meta-analysis versus Biohaven, AbbVie meds
Fierce Pharma
Thu, 09/9/21 - 11:11 am
Teva Pharmaceutical
Eli Lilly
Amgen
Ajovy
Biohaven
migraines
Biohaven CEO on migraine drug's fast launch, TikTok ads and battling big pharma
BioPharma Dive
Wed, 07/14/21 - 10:34 pm
Biohaven
migraines
drug launches
DTC advertising
Nurtec
Pages
« first
‹ previous
1
2
3
4
next ›
last »